3.05
Schlusskurs vom Vortag:
$3.10
Offen:
$3.11
24-Stunden-Volumen:
286.09K
Relative Volume:
0.50
Marktkapitalisierung:
$277.77M
Einnahmen:
$25.14M
Nettoeinkommen (Verlust:
$-21.57M
KGV:
-11.30
EPS:
-0.27
Netto-Cashflow:
$-12.23M
1W Leistung:
+0.00%
1M Leistung:
+8.54%
6M Leistung:
+67.58%
1J Leistung:
+55.61%
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Vergleichen Sie STXS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
STXS
Stereotaxis Inc
|
3.05 | 282.31M | 25.14M | -21.57M | -12.23M | -0.27 |
![]()
ISRG
Intuitive Surgical Inc
|
462.74 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
189.03 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
268.22 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.76 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
279.39 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-01-10 | Eingeleitet | ROTH MKM | Buy |
2022-07-12 | Eingeleitet | Aegis Capital | Buy |
2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
2022-01-05 | Eingeleitet | Craig Hallum | Buy |
2022-01-05 | Eingeleitet | Loop Capital | Buy |
2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
2020-09-08 | Eingeleitet | Northland Capital | Outperform |
2020-04-09 | Eingeleitet | Cowen | Outperform |
2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Can Stereotaxis Inc. stock resist broad market declines2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Visualizing Stereotaxis Inc. stock with heatmaps2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-10-21 19:22:31 - newser.com
Automated trading signals detected on Stereotaxis Inc.July 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com
Can Stereotaxis Inc. stock retain market dominanceEarnings Beat & Weekly Watchlist of Top Performers - newser.com
Stereotaxis (NYSE: STXS) sets Q3 2025 results call and webcast information - Stock Titan
What valuation ratios show for Stereotaxis Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval - sharewise.com
Can Stereotaxis Inc. stock test all time highsForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Will Stereotaxis Inc. stock outperform tech sector in 20252025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Is Stereotaxis Inc. stock attractive for income investorsJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Is Stereotaxis Inc. stock a buy in volatile marketsJuly 2025 Intraday Action & Low Drawdown Trading Strategies - nchmf.gov.vn
Is Stereotaxis Inc. stock a buy on dips2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Stereotaxis Synchrony System Gets European CE Mark; Applies for FDA 510(k) Certification - Diagnostic and Interventional Cardiology
Is Stereotaxis Inc. stock trading near support levelsMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Can Stereotaxis Inc. stock continue upward trendMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Stereotaxis Earns EU Nod for Synchrony System, Submits to FDA - Medical Product Outsourcing
How Stereotaxis Inc. stock stacks up against competitors2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Stereotaxis teams with CardioFocus to develop robotic PFA system - MedTech Dive
Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System - MarketScreener
Stereotaxis (STXS) Moves Forward with Synchrony System Approvals - GuruFocus
Stereotaxis obtains CE mark for Synchrony system, files FDA application By Investing.com - Investing.com Canada
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewswire
CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud - Stock Titan
Order flow analysis tools used on Stereotaxis Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation - sharewise.com
Stereotaxis, CardioFocus Collab to Advance Robotic Pulsed Field Ablation - Medical Product Outsourcing
Stereotaxis (STXS) Partners with CardioFocus to Develop Robotic PFA Technology - GuruFocus
Stereotaxis and CardioFocus partner to develop robotic PFA technology - Investing.com
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewswire
Is Stereotaxis Inc. stock trading at attractive multiplesWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Stereotaxis Inc Stock Analysis and ForecastInstitutional Holding Changes & Free Explosive Portfolio Gains - earlytimes.in
Stereotaxis, Inc. Hits New 52-Week High of $3.58, Marking Key Milestone - Markets Mojo
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):